Ioannis Koumoutsos

Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres

Mark Samaan, Polychronis Pavlidis, Emma Johnston et al. · Frontline Gastroenterology · 2016 · 50 citations · Full text

Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms

Bridgette Wilson, Özge Eyice, Ioannis Koumoutsos et al. · Nutrients · 2021 · 45 citations · Full text

Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study

Mark Samaan, Katrina Forsyth, Jonathan Segal et al. · Journal of Crohn s and Colitis · 2018 · 35 citations

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text

Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity

D C de Jong, Mark Löwenberg, Ioannis Koumoutsos et al. · Inflammatory Bowel Diseases · 2018 · 33 citations · Full text